"Drug-Eluting Stents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Stents that are covered with materials that are embedded with chemicals that are gradually released into the surrounding milieu.
| Descriptor ID |
D054855
|
| MeSH Number(s) |
E07.695.750.500
|
| Concept/Terms |
Drug-Eluting Stents- Drug-Eluting Stents
- Drug Eluting Stents
- Drug-Eluting Stent
- Stent, Drug-Eluting
- Stents, Drug-Eluting
- Stents, Drug Eluting
Drug-Coated Stents- Drug-Coated Stents
- Drug Coated Stents
- Drug-Coated Stent
- Stent, Drug-Coated
- Stents, Drug-Coated
- Stents, Drug Coated
|
Below are MeSH descriptors whose meaning is more general than "Drug-Eluting Stents".
Below are MeSH descriptors whose meaning is more specific than "Drug-Eluting Stents".
This graph shows the total number of publications written about "Drug-Eluting Stents" by people in this website by year, and whether "Drug-Eluting Stents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug-Eluting Stents" by people in Profiles.
-
Abbreviated versus Standard Duration of DAPT after PCI: A Systematic Review and Network Meta-analysis. Am J Cardiovasc Drugs. 2022 Nov; 22(6):633-645.
-
Invasive therapy versus conservative therapy for patients with stable coronary artery disease: An updated meta-analysis. Clin Cardiol. 2021 May; 44(5):675-682.
-
Prolonged use of eptifibatide as a bridge to maintain drug-eluting stent patency in a patient receiving extracorporeal membrane oxygenation. Perfusion. 2018 11; 33(8):699-703.
-
Analysis of neointima development in flow diverters using optical coherence tomography imaging. J Neurointerv Surg. 2018 Feb; 10(2):162-167.
-
State of the art in coronary revascularization: Everolimus eluting stents versus multiple arterial grafting. Int J Cardiol. 2016 Sep 15; 219:345-9.
-
First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1. Catheter Cardiovasc Interv. 2015 Mar; 85 Suppl 1:744-51.
-
Incidence and predictors of definite stent thrombosis after coronary stent implantation. Chin Med J (Engl). 2012 May; 125(9):1547-51.
-
Acceptance, panic, and partial recovery the pattern of usage of drug-eluting stents after introduction in the U.S. (a report from the American College of Cardiology/National Cardiovascular Data Registry). JACC Cardiovasc Interv. 2010 Sep; 3(9):902-10.
-
Temporal changes in the use of drug-eluting stents for patients with non-ST-Segment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the can rapid risk stratification of unstable angina patients supress ADverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) and acute coronary treatment and intervention outcomes network-get with the guidelines (ACTION-GWTG) registries. Circ Cardiovasc Qual Outcomes. 2009 Sep; 2(5):414-20.
-
The drug eluting stent challenge. Am J Ther. 2008 Nov-Dec; 15(6):505.